Cullinan Therapeutics (NasdaqGS:CGEM) 2026 Conference Transcript

Cullinan Therapeutics (NasdaqGS:CGEM) 2026 Conference February 19, 2026 10:00 AM ET Company ParticipantsJeffrey Jones - CMONadim Ahmed - President, CEO and DirectorSamantha Semenkow - VP of SMid Biotech Equity ResearchSamantha SemenkowGood morning, and thank you for joining our session of Citi's Virtual Oncology Leadership Summit. I'm Samantha Semenkow, one of the senior biotech analysts here at Citi, and it's my pleasure today to be hosting Cullinan Therapeutics CEO, Nadim Ahmed, and CMO, Jeff Jones. Nadim ...